BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6086193)

  • 1. Effect of captopril on brain converting enzyme in the spontaneously hypertensive rat.
    Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1984; 11(3):237-44. PubMed ID: 6086193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D
    Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.
    Antonaccio MJ; Rubin B; Horovitz ZP; Laffan RJ; Goldberg ME; High JP; Harris DN; Zaidi I
    Jpn J Pharmacol; 1979 Apr; 29(2):285-94. PubMed ID: 231700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
    Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
    Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of aspirin to modify the hypotensive action of captopril in spontaneously hypertensive rats.
    DiNicolantonio R; Dusting GJ; Hutchinson JS; Mendelsohn FA
    Clin Exp Pharmacol Physiol; 1981 Jul; 8(4):345-9. PubMed ID: 7030543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.
    Okuno T; Nagahama S; Lindheimer MD; Oparil S
    Hypertension; 1983; 5(5):653-62. PubMed ID: 6311736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats.
    Forslund T; Tikkanen I; Grönhagen-Riska C; Fyhrquist F
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):416-21. PubMed ID: 6285670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats.
    Kokubu T; Ueda E; Ono M; Kawabe T; Hayashi Y; Kan T
    Eur J Pharmacol; 1980 Apr; 62(4):269-75. PubMed ID: 6245897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I
    Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the response to captopril in glucocorticoid hypertension.
    Elijovich F; Krakoff LR
    Clin Exp Hypertens A; 1982; 4(9-10):1795-814. PubMed ID: 6291817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril.
    Unger T; Schüll B; Hübner D; Yukimura T; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1981 Jun; 72(2-3):255-9. PubMed ID: 6265248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive action of captopril in angiotensin-salt hypertension.
    Muirhead EE; Brooks B; Brosius WL
    Arch Pathol Lab Med; 1980 Dec; 104(12):631-4. PubMed ID: 7002102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
    Wu JN; Tsai SY; Hsieh WY
    Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium intake on brain angiotensin-converting enzyme activity in spontaneously hypertensive rat.
    Mizuno K; Gotoh M; Fukuchi S
    Tohoku J Exp Med; 1981 Oct; 135(2):217-8. PubMed ID: 6277040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.